Directory
>
Paulo Reis Md Ifacr Imeular
Paulo Reis Md Ifacr Imeular
Vice President, Clinical Design - Immunology, Clinical Development | Eli Lilly and Company
Indianapolis, Indiana, United States
Paulo Reis Md Ifacr Imeular
Summary
Paulo Reis is a highly accomplished Vice President of Clinical Design in Immunology at Eli Lilly and Company, bringing extensive experience in clinical development and medical affairs. With a robust background in rheumatology, he has successfully led the launch of significant assets across various therapeutic areas, including Rheumatology and COVID-19. Trained in Portugal and France, Paulo has also held pivotal roles at the Portuguese Regulatory Agency, contributing to the transformation of the agency and enhancing the market share of generics in Portugal. His leadership extends beyond clinical settings into strategic business management, having directed medical affairs and operational strategies in both the pharmaceutical and healthcare sectors. Paulo's unique blend of medical expertise and business acumen positions him as a key player in advancing healthcare solutions. He is passionate about mentoring future leaders in the field and remains dedicated to improving patient outcomes through innovative drug development.
Paulo Reis Md Ifacr Imeular
Work Experience
Vice President, Clinical Design - Immunology, Clinical Development at
Eli Lilly and Company
June 2023 - Present
Vice President - Head of Global & US Medical Affairs - Immunology Business Unit at
Eli Lilly and Company
March 2023 - June 2023
Head of Global & US Medical Affairs, Rheumatology, Gastroenterology & COVID-19, Immunology BU at
Eli Lilly and Company
March 2022 - February 2023
Sr. Medical Director - Therap Area Leader - Rheumatology, Gastroenterology, COVID-19, Immunology BU at
Eli Lilly and Company
December 2021 - March 2022
Sr. Medical Director - US Medical Affairs, Rheumatology, Gastroenterology & COVID-19, Immunology BU at
Eli Lilly and Company
March 2021 - December 2021
Sr. Medical Director - US Medical Affairs, Rheumatology & COVID-19, Biomedicines BU at
Eli Lilly and Company
June 2020 - March 2021
Sr. Medical Director - US Medical Affairs, Rheumatology, Biomedicines BU at
Eli Lilly and Company
April 2018 - June 2020
Senior Medical Director - US Medical Affairs Dermatology & Inflammation, Biomedicines BU at
Eli Lilly and Company
September 2017 - April 2018
Global Medical Launch Leader, Global Medical Affairs, Taltz (Dermatology & Rheumatology) at
Eli Lilly and Company
February 2017 - August 2017
Assoc. Global Medical Launch Leader, Global Medical Affairs, Olumiant (Psoriatic Arthritis & axSpA) at
Eli Lilly and Company
December 2016 - February 2017
Business Unit Director and Medical Director at
Popular Seguros
August 2006 - November 2016
Business Unit Director and Medical Director at
Eurovida
January 2005 - November 2016
Board Certified Rheumatologist at
José de Mello Saúde
January 2014 - November 2016
Emergency Medicine Physician at
Unidade Local de Saúde de Amadora/Sintra
July 1997 - October 2016
Emergency Medicine Physician at
Hospital Beatriz Angelo
June 2012 - October 2016
Independent Consultant for Pharma (Safety, Regulatory) at
Independentfreelance
March 2005 - September 2016
Board Certified Rheumatologist at
Hospitais da Universidade de Coimbra
May 1998 - March 2005
University of Coimbra - Invited Professor - Rheumatology at
University of Coimbra
September 1999 - January 2005
Head of Division of Medicines for Human Use (Regulatory Agency) at
INFARMED, I.P.
March 2003 - January 2005
Freelance Consultant at
Independent / Freelancer
January 1998 - February 2003
Rheumatologist at
Hospital de Santa Maria
January 1991 - January 1998
Medical Doctor at
Portuguese Air Force
September 1990 - November 1991
Paulo Reis Md Ifacr Imeular
Education
University of Lisbon, Rheumatologist
January 1996
The Lisbon MBA - Católica | NOVA, Master Of Business Administration (Mba)
January 2008 - January 2010
Portuguese Ministry of Health, Consultant
January 1998 - January 2006
Instituto Superior de Gestão, Master Of Business Administration (M.B.A.)
January 2003 - January 2004
University of Lisbon, Doctor Of Medicine - Md
January 1991 - January 1998
Universidade de Lisboa, Doctor Of Medicine (Md)
January 1981 - January 1987
Frequently Asked Questions about Paulo Reis Md Ifacr Imeular
What is Paulo Reis Md Ifacr Imeular email address?
Paulo Reis Md Ifacr Imeular's primary email address is **********@lilly.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Paulo Reis Md Ifacr Imeular work for?
Paulo Reis Md Ifacr Imeular is a Vice President, Clinical Design - Immunology, Clinical Development at Eli Lilly and Company, a company specializing in Biological products, except diagnostic.
Where Paulo Reis Md Ifacr Imeular graduated from?
Paulo Reis Md Ifacr Imeular holds a degree in Medicine from University of Lisbon.
How can I directly contact Paulo Reis Md Ifacr Imeular?
To contact Paulo Reis Md Ifacr Imeular directly, you can use the email address **********@lilly.com. Complete contact information is available upon registration with Muraena.
Who is Paulo Reis Md Ifacr Imeular?
Paulo Reis is a highly accomplished Vice President of Clinical Design in Immunology at Eli Lilly and Company, bringing extensive experience in clinical development and medical affairs. With a robust background in rheumatology, he has successfully led the launch of significant assets across various therapeutic areas, including Rheumatology and COVID-19. Trained in Portugal and France, Paulo has also held pivotal roles at the Portuguese Regulatory Agency, contributing to the transformation of the agency and enhancing the market share of generics in Portugal. His leadership extends beyond clinical settings into strategic business management, having directed medical affairs and operational strategies in both the pharmaceutical and healthcare sectors. Paulo's unique blend of medical expertise and business acumen positions him as a key player in advancing healthcare solutions. He is passionate about mentoring future leaders in the field and remains dedicated to improving patient outcomes through innovative drug development.
Paulo`s contact details
**********@lilly.com
************@mbacatolicanova.com
************@thelisbonmba.com
Colleagues
Executive Director
Senior Vice President, Pricing and Market Access - International
Executive Director - Congress Strategy, Planning & Execution Neuroscience Business Unit
Associate Vice President, Oncology Clinical Trial Acceleration
Associate Vice President- Lilly Research Laboratories Development Capabilities
Associate Vice President Discovery PKPD
Executive Director - Quality Assurance - RegCoR Program Lead
Associate Vice President
Executive Director - Global Orchestration
Executive Director-Immunology Translational Sciences